Q4 2024 Guardian Pharmacy Services Inc Earnings Call Transcript
Key Points
- Guardian Pharmacy Services Inc (GRDN) reported a 20% year-on-year increase in fourth-quarter revenue, reaching $339 million.
- The company achieved a 14% increase in resident count, totaling approximately 186,000 by the end of the quarter.
- Adjusted EBITDA for the fourth quarter rose by 30% compared to the previous year, reaching $26 million.
- For the full year 2024, GRDN generated $1.228 billion in revenue, marking a 17% increase over the previous year.
- The company successfully expanded its footprint by adding nine new pharmacy locations through mergers and acquisitions (M&A) and greenfield startups.
- The company faces potential challenges from the Inflation Reduction Act, which could impact operations in 2026 and beyond.
- Public company costs amounted to over $1 million in 2024, with expectations of these costs increasing to $4 million in 2025.
- New pharmacy locations are contributing very little to the bottom line as they are still scaling.
- The company acknowledges the complexity and operational challenges of administering flu and COVID vaccines, which historically posed profitability headwinds.
- Despite strong growth, the company remains cautious about the potential impact of external factors on its M&A pipeline and market conditions.
Good day, everyone, and welcome to Guardian Pharmacy's Fourth Quarter and Full Year 2024 Earnings Call. (Operator Instructions) Today's speakers will be Fred Burke, President and CEO of Guardian Pharmacy; and David Morris, EVP and CFO of Guardian Pharmacy. Before we begin, I'd like to remind everyone that statements included in this conference call and in the press release issued today may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act. These statements include, but are not limited to, comments regarding our plans, objectives, business outlook and our financial results for 2024 and beyond. Actual results could differ materially from those expressed or implied in forward-looking statements because of a number of risk factors and uncertainties, which are discussed in the company's quarterly report on Form 10-Q and earnings release issued today.
Guardian Pharmacy undertakes no obligations to update any forward-looking statements. Additionally, on today's call, the company will reference certain non-GAAP financial measures, such as EBITDA,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
